Journal
VETERINARY PARASITOLOGY
Volume 101, Issue 1, Pages 75-79Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0304-4017(01)00495-2
Keywords
fecal egg counts; fenbendazole; horse; ivermectin; moxidectin
Categories
Ask authors/readers for more resources
Commercial preparations of fenbendazole (Safe-Guard (R), Intervet), ivermectin (Eqvalan (R), Merial) or moxidectin (Quest (R), Fort Dodge) were administered once to horses scheduled for routine parasiticide treatment. In total, 93 horses from six cooperating farms were used in the study. Computer generated. random allocation of horses to treatment group was conducted at each farm. Fecal egg counts were determined for all horses on trial days 0, 56, 84 and 112, with corresponding calendar dates that were unique to each farm, Only strongyle egg counts from animals which were positive at day 0 were used for analysis of variance and comparisons. Counts for the three treatment groups were similar at day 0, moxidectin < ivermectin < fenbendazole for days 56 and 84, and moxidectin < ivermectin = fenbendazole on day 112 (P < 0.05). Reductions of geometric mean egg counts from day 0 levels were 99.1, 97.6 and 94.9% for moxidectin, 16.4, -27.0 and -32.0% for fenbendazole and 85.9, 124.2 and -8.1% for ivermectin on trial days 56, 84 and 112, respectively. Adverse reactions to treatment were not observed for any of the parasiticides. (C) 2001 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available